Biallelic RFC1 Expansions Are a Rare Cause of Early-Onset and Familial Parkinson's Disease

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Parkinson disease (PD) is a complex neurodegenerative disorder with a significant genetic component.
• Autosomal recessive forms of PD are increasingly recognized, expanding the known genetic landscape.
• The role of specific gene expansions in PD etiology requires further elucidation.

Purpose of the Study:

• To investigate the contribution of biallelic pathogenic expansions in the RFC1 gene to the genetic basis of Parkinson disease.
• To compare the frequency of RFC1 expansions with other known autosomal recessive PD genes.
• To explore potential clinical or genetic distinctions between RFC1-positive and RFC1-negative PD.

Main Methods:

• Genetic analysis of patient cohorts with Parkinson disease.
• Identification and characterization of pathogenic expansions in the RFC1 gene.
• Comparative frequency analysis against established autosomal recessive PD genes.

Main Results:

• Biallelic pathogenic expansions in RFC1 were identified as a contributing factor to the genetic etiology of PD.
• The frequency of RFC1 expansions in PD patients is comparable to that of other established autosomal recessive PD genes.
• Currently, RFC1-positive PD is clinically indistinguishable from RFC1-negative PD.

Conclusions:

• RFC1 expansions represent a notable genetic cause of Parkinson disease.
• The genetic background may influence future therapeutic strategies or interventions for PD.
• Further research is warranted to understand the implications of RFC1 in PD pathogenesis and potential personalized treatments.